ConforMIS Inc. (NASDAQ:CFMS)’s share price was up 4.3% during trading on Thursday . The stock traded as high as $7.25 and last traded at $7.25, with a volume of 134,284 shares trading hands. The stock had previously closed at $6.95.

Several equities analysts have commented on CFMS shares. Oppenheimer Holdings Inc. started coverage on shares of ConforMIS in a report on Saturday, May 14th. They issued a “buy” rating on the stock. Canaccord Genuity reiterated a “buy” rating on shares of ConforMIS in a report on Saturday, May 14th. Deutsche Bank AG decreased their price objective on shares of ConforMIS from $26.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, May 13th. Zacks Investment Research upgraded shares of ConforMIS from a “sell” rating to a “hold” rating in a report on Wednesday, July 13th. Finally, Wells Fargo & Co. downgraded shares of ConforMIS from an “outperform” rating to a “market perform” rating in a report on Friday, May 13th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. ConforMIS has a consensus rating of “Buy” and a consensus target price of $15.20.

The firm’s market cap is $307.16 million. The company’s 50-day moving average is $7.07 and its 200-day moving average is $9.14.

ConforMIS (NASDAQ:CFMS) last posted its quarterly earnings results on Thursday, May 12th. The company reported ($0.37) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.38) by $0.01. The business earned $20.30 million during the quarter, compared to analyst estimates of $19.23 million. ConforMIS’s quarterly revenue was up 38.1% on a year-over-year basis. Analysts anticipate that ConforMIS Inc. will post ($1.38) EPS for the current fiscal year.

An institutional investor recently raised its position in ConforMIS stock. RS Investment Management Co. LLC raised its stake in shares of ConforMIS Inc. (NASDAQ:CFMS) by 3.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,432,470 shares of the company’s stock after buying an additional 43,490 shares during the period. RS Investment Management Co. LLC owned 3.52% of ConforMIS worth $24,767,000 at the end of the most recent quarter.

ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.